| Details announced of improvements to mesothelioma compensation system
John Hutton today gave details of how the system for compensating sufferers of mesothelioma, the debilitating form of lung cancer caused by exposure to asbestos, would be improved and speeded up. After working with key stakeholders, the Secretary of State for Work and Pensions said interim measures to speed up current claims would be put into action and he was determined to put in place a long-term solution. "I am committed to ensuring sufferers of this awful disease, which progresses so rapidly from the time of diagnosis, will get compensation before they die," said Mr Hutton. "There are a series of measures we will put into action straight away, such as clarifying with claims handlers best practice to ensure priority is given to those with mesothelioma.
Alfacell Corporation Announces Common Stock and Warrant Offering ...
BLOOMFIELD, N.J., July 20 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL - News) announced today that the Company has closed a private equity placement led by ProMed Management, Inc. and several other select institutional and individual investors to purchase 6,457,172 shares of its common stock at a price of $1.75 per share. Additionally, the Company issued to the investors two sets of Warrants as set forth and described below: The offering provided gross proceeds of approximately $11.3 million to Alfacell before deducting certain fees and expenses. The proceeds of the financing will be used for general corporate purposes and, most importantly, to support the Company's three-year strategic plan. Concurrent with the purchase agreement with the investors in the financing, the Company agreed to amend currently outstanding warrants to purchase 1,374,585 shares held by certain investors in the financing.
Agency awards payout to asbestos victim's widow
The Environmental Restoration and Conservation Agency recognized Tuesday the death of a man in 1997 as being caused by mesothelioma triggered by breathing asbestos from his father's asbestos-contaminated clothing, sources said Friday. According to the independent administrative institute, it decided to pay condolence money to the bereaved family of Hitoshi Kosuge, 42, from Saitama, based on the new law to aid asbestos victims. The independent administration's recognition runs against a Supreme Court ruling. Kosuge's widow, Chieko, 51, filed a lawsuit in 2000 seeking compensation. Hitoshi's father worked for a company manufacturing asbestos cement pipes. Chieko filed a suit seeking 94 million yen compensation from the company, claiming Hitoshi died of secondary damage by asbestos that clung to his father's work clothes.
Compensation speeded up for asbestos cancer claims
PEOPLE suffering from lung cancer after being exposed to asbestos will receive compensation more quickly under moves introduced by the government yesterday. John Hutton, the Work and Pensions Secretary, said the system would be speeded up to ensure people suffering from mesothelioma received their money before they died. He said interim measures to speed up the claims process would be put into action now.. About 1,800 people are currently diagnosed with mesothelioma each year, and as many as 2,400 people could die from it annually by 2013. But while the disease has a long latency period, people typically die within 12 to 18 months of having it diagnosed. Under the new measures insurance claims handlers will be told to give priority to mesothelioma claims.
Alimta® or with Platinol® Benefits Patients with Recurrent Mesothelioma
According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta® (pemetrexed) with or without the chemotherapy agent Platinol® (cisplatin) provides benefit for patients with malignant mesothelioma who have received prior therapies. Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. It is often caused by chronic exposure to asbestos. The majority of patients are not diagnosed until the disease has progressed to an advanced stage and treatment with surgery or radiation is not an option. Patients with this disease often experience symptoms, such as shortness of breath, cough, pain, fatigue, and an inability to eat, which lessen their quality of life.
|
